[Progress of integrative medicine, human papillomavirus vaccine and molecular targeted therapy for cervical cancer].
Cho
Chi-Shing
CS
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China. chocs@ha.org.hk
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology / Q000472:pathogenicity; D052161:Human papillomavirus 18 / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D055048:Integrative Medicine; D008516:Medicine, Chinese Traditional; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D008517:Phytotherapy; D002583:Uterine Cervical Neoplasms / Q000601:surgery / Q000628:therapy* / Q000821:virology; D014626:Vaginal Smears
D019496:Cancer Vaccines; D004365:Drugs, Chinese Herbal; D053918:Papillomavirus Vaccines